Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients
2002 | journal article
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Jacob, S., Poeggeler, B., Weishaupt, J. H., Sirén, Anna-Leena, Hardeland, R., Bähr, M. & Ehrenreich, H. (2002). Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients. Journal of Pineal Research, 33(3), 186-187. doi: https://doi.org/10.1034/j.1600-079X.2002.02943.x
